Perceptive Capital Solutions Corp
Business
Perceptive Capital Solutions Corp is a blank check company formed to identify and complete a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. It provides a platform for effecting an initial business combination, including sourcing opportunities, conducting due diligence, structuring transactions and facilitating public listing through its trust account and sponsor arrangements. The company targets the healthcare sector—particularly life sciences and medical technology—and leverages Perceptive Advisors’ investment expertise and networks. It focuses on target companies in North America and Europe and uses public markets and negotiated transactions to consummate combinations.
Summary from filing dated 2025-03-19
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 |
|---|---|---|
| General and administrative expenses | 3 | |
| Loss from operations | −3 | |
| Interest earned on investments held in Trust Account | 4 | |
| Unrealized (loss) gain on investments held in Trust Account | −3,298 | |
| Total other income, net | 4 | |
| Net income | 837,468 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2024 2024-03-31 |
|---|---|---|---|---|
| Cash | 865,031 | 1 | — | |
| Prepaid expenses | 42,539 | 115,006 | — | |
| Total Current Assets | 907,570 | 1 | — | |
| Cash and investments held in Trust Account | 92 | 89 | — | |
| Total Assets | 93 | 90 | — | |
| Accrued expenses | 2 | 210,811 | — | |
| Total Current Liabilities | 2 | 210,811 | — | |
| Deferred underwriting fee | 3 | 3 | — | |
| Total Liabilities | 6 | 4 | — | |
| Commitments and Contingencies (Note 5) | — | — | — | |
| Class A ordinary shares subject to possible redemption, 8,625,000 shares at redemption value of approximately $10.65 and $10.24 per share as of December 31, 2025 and 2024, respectively | 92 | 88 | — | |
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of December 31, 2025 and 2024 | 0 | 0 | — | |
| Accumulated deficit | −5 | −2 | — | |
| Total Shareholders Deficit | −5 | −2 | 0 | |
| Total Liabilities and Shareholders Deficit | 93 | 90 | — |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 |
|---|---|---|
| Payment of operating costs through promissory note | 0 | |
| Prepaid expenses and other current assets | 72,467 | |
| Accrued expenses | 2 | |
| Net cash used in operating activities | −864,653 | |
| Investment of cash in Trust Account | 0 | |
| Cash withdrawn from Trust Account for working capital purposes | 600,000 | |
| Net cash provided by (used in) investing activities | 600,000 | |
| Proceeds from sale of shares, net of underwriting discounts paid | 0 | |
| Proceeds from sale of Private Placement Shares | 0 | |
| Underwriter reimbursement | 0 | |
| Repayment of promissory note related party | 0 | |
| Payment of offering costs | 0 | |
| Net cash provided by financing activities | 0 | |
| Net Change in Cash | −264,653 | |
| Deferred offering costs paid directly by Sponsor in exchange for the issuance of Class B ordinary shares | 0 | |
| Deferred offering costs paid through promissory note - related party | 0 |